1. Home
  2. ROMA vs SNTI Comparison

ROMA vs SNTI Comparison

Compare ROMA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROMA
  • SNTI
  • Stock Information
  • Founded
  • ROMA 2018
  • SNTI 2016
  • Country
  • ROMA Hong Kong
  • SNTI United States
  • Employees
  • ROMA N/A
  • SNTI N/A
  • Industry
  • ROMA Savings Institutions
  • SNTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROMA Finance
  • SNTI Health Care
  • Exchange
  • ROMA Nasdaq
  • SNTI Nasdaq
  • Market Cap
  • ROMA 58.1M
  • SNTI 50.3M
  • IPO Year
  • ROMA 2024
  • SNTI N/A
  • Fundamental
  • Price
  • ROMA $3.92
  • SNTI $1.80
  • Analyst Decision
  • ROMA
  • SNTI Strong Buy
  • Analyst Count
  • ROMA 0
  • SNTI 2
  • Target Price
  • ROMA N/A
  • SNTI $8.50
  • AVG Volume (30 Days)
  • ROMA 252.8K
  • SNTI 514.0K
  • Earning Date
  • ROMA 08-05-2025
  • SNTI 08-12-2025
  • Dividend Yield
  • ROMA N/A
  • SNTI N/A
  • EPS Growth
  • ROMA N/A
  • SNTI N/A
  • EPS
  • ROMA N/A
  • SNTI N/A
  • Revenue
  • ROMA $1,029,120.00
  • SNTI N/A
  • Revenue This Year
  • ROMA N/A
  • SNTI N/A
  • Revenue Next Year
  • ROMA N/A
  • SNTI $150.00
  • P/E Ratio
  • ROMA N/A
  • SNTI N/A
  • Revenue Growth
  • ROMA N/A
  • SNTI N/A
  • 52 Week Low
  • ROMA $0.46
  • SNTI $1.52
  • 52 Week High
  • ROMA $4.66
  • SNTI $16.94
  • Technical
  • Relative Strength Index (RSI)
  • ROMA 60.19
  • SNTI 32.92
  • Support Level
  • ROMA $3.82
  • SNTI $1.86
  • Resistance Level
  • ROMA $4.66
  • SNTI $2.12
  • Average True Range (ATR)
  • ROMA 0.32
  • SNTI 0.15
  • MACD
  • ROMA 0.02
  • SNTI 0.01
  • Stochastic Oscillator
  • ROMA 48.58
  • SNTI 12.92

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: